COMPARING AN OPERATION TO MONITORING, WITH OR WITHOUT ENDOCRINE THERAPY (COMET) FOR LOW RISK DCIS: A PHASE III PROSPECTIVE RANDOMIZED TRIAL
Categories (click each to see list of all clinical trials associated with that category): Breast (ONC)
Current Status: Open
Phase: III
Principal Investigator: Maxwell, Jessica
Contact Information:
Shara Graalfs
+1 402-596-3151
shara.graalfs@unmc.edu
Eligibility: https://clinicaltrials.gov/ct2/show/NCT02926911?cond=NCT02926911&draw=2&rank=1#eligibility
Summary
Primary Objectives:
To assess whether 2-year ipsilateral invasive cancer rate for AS is non-inferior to that for GCC.
Secondary Objectives:
To determine whether AS is non-inferior to GCC for the following outcomes: 2-year mastectomy rate, breast conservation rate; 2-year contralateral invasive breast cancer rate; 2-year overall survival and breast cancer specific survival; health-related QOL at 1 year, 2 years; anxiety and depression and other psychosocial outcomes at 1 year, 2 years